NCT03965078View on ClinicalTrials.gov

Epiretinal Membrane and Cystoid Macular Oedema Post-cataract Surgery

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

June 21, 2018

Primary Completion Date

July 13, 2022

Study Completion Date

July 15, 2022

Conditions
Pseudophakic Cystoid Macular OedemaEpiretinal Membrane
Interventions
DRUG

topical (eye drop) anti-inflammatories

Initial treatment with topical anti-inflammatory eye drops at the discretion of the reviewing clinician

Trial Locations (1)

PO6 3LY

Portsmouth Hospitals Trust, Portsmouth

All Listed Sponsors
lead

Portsmouth Hospitals NHS Trust

OTHER_GOV

NCT03965078 - Epiretinal Membrane and Cystoid Macular Oedema Post-cataract Surgery | Biotech Hunter | Biotech Hunter